Work

VLP-expressing DNA/MVA Vaccines: The Effect of Schedule and Regimen on Antibody Magnitude and Avidity

Year: 2014

Type: conference-abstract

Source: AIDS Research and Human Retroviruses

DOI: 10.1089/aid.2014.5050.abstract

Authors: Susan P. Buchbinder, Christine Hay, Nicole Grunenberg, Paul Goepfert, Tomaras Georgia, Kelly Seaton, Alicia Sato, Marnie Elizaga, Xuesong Yu, Peter Gilbert, Bernard Moss, Harriet Robinson

Institutions: University of California, San Francisco, San Francisco Department of Public Health, University of Rochester Medicine, University of Rochester, Fred Hutch Cancer Center, University of Alabama at Birmingham, Duke University, National Institutes of Health, National Institute of Allergy and Infectious Diseases, GeoVax (United States)

Language: English

Topic: HIV Research and Treatment

Subfield: Virology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2339561908

Cites:

Cited by:

Related to: 10